文献速递呼吸道感染呼吸危重症与机械通气

呼吸道气溶胶排放:供氧系统的气溶胶生成分析

Aerosol emission from the respiratory tract: an analysis of aerosol generation from oxygen delivery systems.
PubMed 文献 · Thorax · 2021-11-04

该研究在健康志愿者中比较持续气道正压通气(CPAP)、经鼻高流量氧疗(HFNO)与呼吸、说话、咳嗽的气溶胶排放,并记录COVID-19住院患者咳嗽。结果显示CPAP(带呼气口过滤器)气溶胶排放少于呼吸、说话和咳嗽;HFNO相关气溶胶来自机器且颗粒小(<1 µm),不太可能携带病毒;咳嗽是排放最高的活动。

要点

  • 标准非湿化CPAP的气溶胶排放少于呼吸、说话和咳嗽。
  • HFNO相关气溶胶来自机器,颗粒<1 µm,不太可能携带病毒。
  • 咳嗽是所有测量活动中气溶胶排放最高的活动。

核心结论

  • 在健康志愿者中,标准非湿化CPAP的气溶胶排放少于呼吸、说话或咳嗽。
  • HFNO似乎不增加呼吸道气溶胶排放,其颗粒来自机器且小于1 µm,不太可能携带病毒。
  • 咳嗽似乎是所有测量活动中主要的气溶胶生成风险。

研究设计与样本

  • 健康志愿者在超洁净层流手术室中依次进行呼吸、说话、咳嗽以及使用CPAP和HFNO。
  • 采用两种独立方法同时测量气溶胶排放。
  • COVID-19住院患者在感染病病房用相同方法记录咳嗽。

主要发现

  • 健康志愿者共25名,531次测量。
  • CPAP(带呼气口过滤器)产生的气溶胶少于呼吸、说话和咳嗽,即使面罩漏气>50 L/min。
  • 咳嗽是所有记录活动中气溶胶排放最高的。
  • HFNO相关的颗粒小(<1 µm),从机器经患者到探测器,未与呼吸道气溶胶合并。
  • COVID-19患者(n=8)咳嗽产生的气溶胶多于志愿者。

临床怎么用

  • 标准非湿化CPAP和HFNO不应仅因气溶胶生成而被视为高风险操作。
  • 咳嗽是气溶胶生成的主要风险,应加强咳嗽管理。
  • HFNO产生的颗粒来自机器且小,不太可能携带病毒。

局限性

  • 直接比较复杂。
  • 实验在超洁净层流手术室进行,可能影响气溶胶测量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: continuous positive airway pressure (CPAP) and high-flow nasal oxygen (HFNO) provide enhanced oxygen delivery and respiratory support for patients with severe COVID-19. CPAP and HFNO are currently designated as aerosol-generating procedures despite limited high-quality experimental data. We aimed to characterise aerosol emission from HFNO and CPAP and compare with breathing, speaking and coughing. MATERIALS AND METHODS: Healthy volunteers were recruited to breathe, speak and cough in ultra-clean, laminar flow theatres followed by using CPAP and HFNO. Aerosol emission was measured using two discrete methodologies, simultaneously. Hospitalised patients with COVID-19 had cough recorded using the same methodology on the infectious diseases ward. RESULTS: In healthy volunteers (n=25 subjects; 531 measures), CPAP (with exhalation port filter) produced less aerosol than breathing, speaking and coughing (even with large >50 L/min face mask leaks). Coughing was associated with the highest aerosol emissions of any recorded activity. HFNO was associated with aerosol emission, however, this was from the machine. Generated particles were small (<1 µm), passing from the machine through the patient and to the detector without coalescence with respiratory aerosol, thereby unlikely to carry viral particles. More aerosol was generated in cough from patients with COVID-19 (n=8) than volunteers. CONCLUSIONS: In healthy volunteers, standard non-humidified CPAP is associated with less aerosol emission than breathing, speaking or coughing. Aerosol emission from the respiratory tract does not appear to be increased by HFNO. Although direct comparisons are complex, cough appears to be the main aerosol-generating risk out of all measured activities.

来源:Thorax,查看原文。版权归原作者所有。

引用

  1. Hamilton FW, Gregson FKA, Arnold DT, et al. Aerosol emission from the respiratory tract: an analysis of aerosol generation from oxygen delivery systems. Thorax. 2021. PMID: 34737195. doi:10.1136/thoraxjnl-2021-217577

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。